Letters Section Editor: Robert M. Golub, MD, Senior Editor.
To the Editor: In their study of thrombosis after implantation of drug-eluting stents, Dr Iakovou and colleagues1 concluded that premature discontinuation of antiplatelet therapy was the strongest predictor of subacute or late thrombotic occlusion of drug-eluting stents. This is a major issue, given the increasing rate of drug-eluting stent implantation with a prolonged indication for dual-antiplatelet therapy. The study does not provide reasons 17 patients stopped using the oral antiplatelet agent. This information is important for a number of reasons.
Marret E, Collet J, Albaladejo P, Montalescot G. Thrombosis After Implantation of Drug-Eluting Stents. JAMA. 2006;295(1):36. doi:10.1001/jama.295.1.36-a